Boanmycin overcomes bortezomib resistance by inducing DNA damage and endoplasmic reticulum functional impairment in multiple myeloma

Abstract Background Multiple myeloma (MM) is a hematological malignancy characterized by uncontrolled proliferation of plasma cells and is currently incurable. Despite advancements in therapeutic strategies, resistance to proteasome inhibitors, particularly bortezomib (BTZ), poses a substantial chal...

Full description

Saved in:
Bibliographic Details
Main Authors: Jin-Xing Wang, Ling Zhang, Peng-Wei Zhang, Luo-Wei Yuan, Jian Jiang, Xiao-Hui Cheng, Wei Zhu, Yong Lei, Fa-Qing Tian
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Biology Direct
Subjects:
Online Access:https://doi.org/10.1186/s13062-024-00590-y
Tags: Add Tag
No Tags, Be the first to tag this record!